These findings confirm that cyclobrachycoumarin inhibits CRC cell proliferation by promoting ROS generation, down-regulating the apoptosis inhibitory protein survivin and cell cycle-related proteins cyclin D1 and CDK1, and up-regulating the pro-apoptotic protein cleaved PARP. This evidence concerns the gene BIRC5 and colorectal carcinoma.